Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. Lancet 397(10291):2284–2303. https://doi.org/10.1016/s0140-6736(21)00218-x

Article  CAS  PubMed  Google Scholar 

Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 20(5):385–397. https://doi.org/10.1016/s1474-4422(21)00030-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15(12):1257–1272. https://doi.org/10.1016/s1474-4422(16)30230-7

Article  PubMed  Google Scholar 

Church FC (2021) Treatment options for motor and non-motor symptoms of Parkinson’s disease. Biomolecules 11(4):612. https://doi.org/10.3390/biom11040612

Reich SG, Savitt JM (2019) Parkinson’s disease. Med Clin North Am 103(2):337–350. https://doi.org/10.1016/j.mcna.2018.10.014

Article  PubMed  Google Scholar 

Hussein A, Guevara CA, Del Valle P, Gupta S, Benson DL, Huntley GW (2021) Non-motor symptoms of Parkinson’s disease: the neurobiology of early psychiatric and cognitive dysfunction. Neuroscientist 29(1):97–116. https://doi.org/10.1177/10738584211011979

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435–450. https://doi.org/10.1038/nrn.2017.62

Article  CAS  PubMed  Google Scholar 

Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46:S30–S33. https://doi.org/10.1016/j.parkreldis.2017.07.033

Article  PubMed  Google Scholar 

Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial dysfunction and mitophagy in Parkinson’s disease: from mechanism to therapy. Trends Biochem Sci 46(4):329–343. https://doi.org/10.1016/j.tibs.2020.11.007

Article  CAS  PubMed  Google Scholar 

Dionísio PA, Amaral JD, Rodrigues CMP (2021) Oxidative stress and regulated cell death in Parkinson’s disease. Ageing Res Rev 67:101263. https://doi.org/10.1016/j.arr.2021.101263

Article  CAS  PubMed  Google Scholar 

Wang T, Shi C, Luo H, Zheng H, Fan L, Tang M et al (2021) Neuroinflammation in Parkinson’s disease: triggers, mechanisms, and immunotherapies. Neuroscientist 28(4):364–381. https://doi.org/10.1177/1073858421991066

Article  CAS  PubMed  Google Scholar 

Jankovic J, Tan EK (2020) Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795–808. https://doi.org/10.1136/jnnp-2019-322338

Article  PubMed  Google Scholar 

Badanjak K, Fixemer S, Smajić S, Skupin A, Grünewald A (2021) The contribution of microglia to neuroinflammation in Parkinson’s Disease. Int J Mol Sci 22(9):4676. https://doi.org/10.3390/ijms22094676

Article  CAS  PubMed  PubMed Central  Google Scholar 

Isik S, YemanKiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson’s Disease. Cells 12(7):1012. https://doi.org/10.3390/cells12071012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palumbo L, Carinci M, Guarino A, Asth L, Zucchini S, Missiroli S et al (2023) The NLRP3 inflammasome in neurodegenerative disorders: insights from epileptic models. Biomedicines 11(10):2825. https://doi.org/10.3390/biomedicines11102825

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson FL, Biggs KE, Rankin BE, Havrda MC (2023) NLRP3 inflammasome in neurodegenerative disease. Transl Res 252:21–33. https://doi.org/10.1016/j.trsl.2022.08.006

Article  CAS  PubMed  Google Scholar 

Picca A, Faitg J, Auwerx J, Ferrucci L, D’Amico D (2023) Mitophagy in human health, ageing and disease. Nat Metab 5(12):2047–2061. https://doi.org/10.1038/s42255-023-00930-8

Article  PubMed  Google Scholar 

Lou G, Palikaras K, Lautrup S, Scheibye-Knudsen M, Tavernarakis N, Fang EF (2020) Mitophagy and neuroprotection. Trends Mol Med 26(1):8–20. https://doi.org/10.1016/j.molmed.2019.07.002

Article  CAS  PubMed  Google Scholar 

Madsen DA, Schmidt SI, Blaabjerg M, Meyer M (2021) Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease. Cells 10(2):283. https://doi.org/10.3390/cells10020283

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang T-SZ, Sun Y, Pearce AC, Eleuteri S, Kemp M, Luckhurst CA et al (2023) Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model. Nat Commun 14(1):7295. https://doi.org/10.1038/s41467-023-42876-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M et al (2016) Parkinson’s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell 166(2):314–327. https://doi.org/10.1016/j.cell.2016.05.039

Article  CAS  PubMed  Google Scholar 

Walsh TG, van den Bosch MTJ, Lewis KE, Williams CM, Poole AW (2018) Loss of the mitochondrial kinase PINK1 does not alter platelet function. Sci Rep 8(1):14377. https://doi.org/10.1038/s41598-018-32716-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braun MM, Puglielli L (2022) Defective PTEN-induced kinase 1/Parkin mediated mitophagy and neurodegenerative diseases. Front Cell Neurosci 16:1031153. https://doi.org/10.3389/fncel.2022.1031153

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pickrell AM, Youle RJ (2015) The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron 85(2):257–273. https://doi.org/10.1016/j.neuron.2014.12.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imberechts D, Kinnart I, Wauters F, Terbeek J, Manders L, Wierda K et al (2022) DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy. Brain 145(12):4368–4384. https://doi.org/10.1093/brain/awac313

Article  PubMed  PubMed Central  Google Scholar 

Liu H, Ho PW-L, Leung C-T, Pang SY-Y, Chang EES, Choi ZY-K et al (2020) Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2R1441Gmice. Autophagy 17(10):3196–3220. https://doi.org/10.1080/15548627.2020.1850008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franco R, Hatori Y, Kanda Y, Nonaka S, Nakanishi H, Kitazawa T (2022) ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway. Plos One 17(11):e0276823. https://doi.org/10.1371/journal.pone.0276823

Article  CAS  Google Scholar 

Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA (2022) Mitochondrial quality control in health and in Parkinson’s disease. Physiol Rev 102(4):1721–1755. https://doi.org/10.1152/physrev.00041.2021

Article  CAS